SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients (Q79699292)
Jump to navigation
Jump to search
scientific article published on 30 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients |
scientific article published on 30 January 2007 |
Statements
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients (English)
Jean-Marc Guinebretière
Jean-Claude Gentet
Hélène Pacquement
Fabienne Pichon
Perrine Marec-Bérard
Natacha Entz-Werlé
Claudine Schmitt
Laurence Brugières
Daniel Vanel
Noëlle Dupoüy
Marie-Dominique Tabone
Chantal Kalifa
Société Française d'Oncologie Pédiatrique (SFOP)
30 January 2007